Molina Healthcare Inc. (NYSE:MOH) is considered one of the most undervalued mid-cap stocks to buy now. Goldman Sachs lowered its price target to $124 from $167 after the company’s Q4 2025 earnings miss. UBS analyst AJ Rice also lowered the price target to $145 from $170, citing Medicaid and exchanges challenges.

Molina Healthcare Inc. (NYSE:MOH) provides managed healthcare services to low-income families and individuals under Medicaid, Medicare, and state insurance marketplaces in the US. It operates in four segments: Medicaid, Medicare, Marketplace, and Other.

While Molina Healthcare (MOH) shows potential as an investment, some AI stocks may offer greater upside and less downside risk. For those interested in an undervalued AI stock with benefits from Trump-era tariffs and onshoring trend, check out the free report on the best short-term AI stock.

Read more at Yahoo Finance: Molina Healthcare (MOH) PT Lowered to $124 by Goldman Sachs Following Q4 Earnings Miss